We are live on ! Find out more
PVCT

PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT

Delisted

PVCT was delisted on the 13th of October, 2016.

Back to rankings

5 hedge funds and large institutions have $8K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

67% more funds holding

Funds holding: 3 → 5 (+2)

33% more capital invested

Capital invested by funds: $6K → $8K (+$2K)

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LDB
Lee, Danner & Bass
Tennessee
+$2K
2
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$1K
3
CCB
Cutter & Co Brokerage
Missouri
+$1K

Top Sellers

Rank Fund Capital Flow
1
ACM
Academy Capital Management
Texas
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
HFBOT
1
Home Federal Bank of Tennessee
Tennessee
$4K – – –
LDB
2
Lee, Danner & Bass
Tennessee
$2K +$2K +50,000 New
CAPTRUST Financial Advisors
3
CAPTRUST Financial Advisors
North Carolina
$1K +$1K +21,657 New
CCB
4
Cutter & Co Brokerage
Missouri
$1K +$1K +26,000 New
ACM
5
Academy Capital Management
Texas
– -$1K -20,000 Closed

PVCT Hedge Fund Activity: Q2 2020 in Review

5 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q2 2020, worth a combined $8K — up 33% from $6K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PVCT positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Lee, Danner & Bass, opening a new position worth an estimated $2K. The largest seller was Academy Capital Management, exiting entirely with an estimated $1K sold.

  • 5 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q2 2020, up from 3 in Q1 2020.
  • Funds reported $8K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q2 2020, up 33% quarter-over-quarter.
  • 3 funds opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q2 2020 and 1 closed out, a net change of +2 holders.
  • The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) buyer in Q2 2020 was Lee, Danner & Bass, an estimated $2K added.
  • The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) seller in Q2 2020 was Academy Capital Management, an estimated $1K sold.

Based on aggregated 13F filings for Q2 2020.